Angelika D Manthripragada
Overview
Explore the profile of Angelika D Manthripragada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serban M, Colantonio L, Manthripragada A, Monda K, Bittner V, Banach M, et al.
J Am Coll Cardiol
. 2017 Mar;
69(11):1386-1395.
PMID: 28302290
Background: Many patients report adverse reactions to, and may not tolerate, statin therapy. These patients may be at increased risk for coronary heart disease (CHD) events and mortality. Objectives: This...
2.
Schmidt S, Heide-Jorgensen U, Manthripragada A, Ehrenstein V
Clin Epidemiol
. 2015 Mar;
7:201-12.
PMID: 25759600
Background: With the emergence of new lipid-lowering therapies, more patients are expected to achieve substantial lowering of low-density lipoprotein cholesterol (LDL-C). However, there are limited data examining the clinical experience...
3.
Manthripragada A, Pinheiro S, MaCurdy T, Saneinejad S, Worrall C, Kelman J, et al.
Pediatrics
. 2013 Oct;
132(5):e1327-32.
PMID: 24127469
Objective: To assess off-label use of the topical calcineurin inhibitors (TCIs), tacrolimus and pimecrolimus, in children during periods before and after regulatory action by the US Food and Drug Administration...
4.
Manthripragada A, Schernhammer E, Qiu J, Friis S, Wermuth L, Olsen J, et al.
Neuroepidemiology
. 2011 Apr;
36(3):155-61.
PMID: 21508649
Background: Experimental evidence supports a preventative role for non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease (PD). Methods: We investigated associations between use of aspirin, nonaspirin NSAIDs, and acetaminophen and PD...
5.
Manthripragada A, Zhou E, Budnitz D, Lovegrove M, Willy M
Pharmacoepidemiol Drug Saf
. 2011 Feb;
20(8):819-26.
PMID: 21294217
Purpose: To estimate the number of acetaminophen overdose-related emergency department (ED) visits and hospitalizations in the United States, characterize these by intentionality, age, and gender, and compare the strengths and...
6.
Gatto N, Rhodes S, Manthripragada A, Bronstein J, Cockburn M, Farrer M, et al.
Neuroepidemiology
. 2010 Jul;
35(3):191-5.
PMID: 20664293
Background: Although of great interest and suggested in prior reports, possible α-synuclein (SNCA) gene-environment interactions have not been well investigated in humans. Methods: We used a population-based approach to examine...
7.
Ritz B, Manthripragada A, Qian L, Schernhammer E, Wermuth L, Olsen J, et al.
Mov Disord
. 2010 Jul;
25(9):1210-6.
PMID: 20629142
The objective of this study was to investigate whether statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor) use is associated with risk of Parkinson's disease (PD) in Denmark. We identified 1,931 patients with...
8.
Gatto N, Cockburn M, Bronstein J, Manthripragada A, Ritz B
Environ Health Perspect
. 2010 Jan;
117(12):1912-8.
PMID: 20049211
Introduction: Investigators have hypothesized that consuming pesticide-contaminated well water plays a role in Parkinson's disease (PD), and several previous epidemiologic studies support this hypothesis. Objectives: We investigated whether consuming water...
9.
Manthripragada A, Costello S, Cockburn M, Bronstein J, Ritz B
Epidemiology
. 2009 Nov;
21(1):87-94.
PMID: 19907334
Background: Human, animal and cell models support a role for pesticides in the etiology of Parkinson disease. Susceptibility to pesticides may be modified by genetic variants of xenobiotic enzymes, such...
10.
Ritz B, Manthripragada A, Costello S, Lincoln S, Farrer M, Cockburn M, et al.
Environ Health Perspect
. 2009 Jul;
117(6):964-9.
PMID: 19590691
Background: Research suggests that independent and joint effects of genetic variability in the dopamine transporter (DAT) locus and pesticides may influence Parkinson's disease (PD) risk. Materials: Methods: In 324 incident...